🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Severe congenital neutropenia (SCN) is a group of primary immunodeficiencie...
Status
Unknown
Location
HSCT department
Start Date
2021-04-14
Trial ID
NCT04844177
Treatments Being Tested
This study seeks to determine if administration of the drug belumosudil (KD...
Status
Active Not Recruiting
Location
University of California, Los Angeles
Start Date
2023-07-07
Trial ID
NCT05806749
Treatments Being Tested
This is a phase II multi-institutional therapeutic study of a non-myeloabla...
Status
Withdrawn
Location
Masonic Cancer Center
Start Date
2018-10-30
Trial ID
NCT03365661
Treatments Being Tested
This pilot research study is to investigate the safety and effectiveness of...
Status
Completed
Location
University of Michigan Cancer Center
Start Date
2008-12
Trial ID
NCT00763490
The present project aims at comparing two nonmyeloablative regimens current...
Status
Completed
Location
AZ Gasthuisberg Leuven
Start Date
2008-01
Trial ID
NCT00603954
Treatments Being Tested
The purpose of this study is to evaluate whether addition of a low dose of ...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2018-11-05
Trial ID
NCT03734601
This phase I trial is to find out the best dose, possible benefits and/or s...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2022-07-19
Trial ID
NCT05139004
In this study, participants with high-risk hematologic malignancies undergo...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2013-05-16
Trial ID
NCT01807611
Multiple conditioning regimens have been used for the HSCT, some of which i...
Status
Completed
Location
Andres Gomez
Start Date
2023-09-01
Trial ID
NCT06209190
Treatments Being Tested
This is a Phase 1b study of participants with Diffuse Large B Cell Lymphoma...
Status
Withdrawn
Location
Princess Margaret Cancer Centre
Start Date
2024-04-05
Trial ID
NCT06003179
Treatments Being Tested